Apollo Medical Holdings Inc
NASDAQ:ASTH
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
32.96
62.54
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one ASTH stock under the Base Case scenario is 57.11 USD. Compared to the current market price of 42.11 USD, Apollo Medical Holdings Inc is Undervalued by 26%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Apollo Medical Holdings Inc
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for ASTH cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Apollo Medical Holdings Inc
Balance Sheet Decomposition
Apollo Medical Holdings Inc
Current Assets | 597m |
Cash & Short-Term Investments | 350.3m |
Receivables | 226.1m |
Other Current Assets | 20.5m |
Non-Current Assets | 688.4m |
Long-Term Investments | 43.5m |
PP&E | 45.3m |
Intangibles | 518.8m |
Other Non-Current Assets | 80.8m |
Current Liabilities | 312.9m |
Accounts Payable | 60.4m |
Accrued Liabilities | 22.7m |
Other Current Liabilities | 229.8m |
Non-Current Liabilities | 267.8m |
Long-Term Debt | 423.9m |
Other Non-Current Liabilities | -156m |
Earnings Waterfall
Apollo Medical Holdings Inc
Revenue
|
1.7B
USD
|
Cost of Revenue
|
-1.5B
USD
|
Gross Profit
|
259.9m
USD
|
Operating Expenses
|
-175.1m
USD
|
Operating Income
|
84.8m
USD
|
Other Expenses
|
-22.3m
USD
|
Net Income
|
62.5m
USD
|
Free Cash Flow Analysis
Apollo Medical Holdings Inc
USD | |
Free Cash Flow | USD |
Astrana Health began 2024 with notable financial and operational achievements. The company reported a 20% increase in total revenue, reaching $404 million, and a 42% growth in adjusted EBITDA, now at $42.2 million, yielding a margin of 10.4%. This growth was driven by a mix of organic membership expansion and acquisitions. Membership grew by 10% organically, excluding strategic acquisitions. The company also foresees a single-digit uplift in Q2 revenue due to acquisitions. Astrana reaffirmed its full-year guidance, highlighting a strong and sustainable business trajectory. Key investments in technology and new market operations are expected to continue driving growth and profitability.
What is Earnings Call?
ASTH Profitability Score
Profitability Due Diligence
Apollo Medical Holdings Inc's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
Score
Apollo Medical Holdings Inc's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
ASTH Solvency Score
Solvency Due Diligence
Apollo Medical Holdings Inc's solvency score is 57/100. The higher the solvency score, the more solvent the company is.
Score
Apollo Medical Holdings Inc's solvency score is 57/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ASTH Price Targets Summary
Apollo Medical Holdings Inc
According to Wall Street analysts, the average 1-year price target for ASTH is 64.76 USD with a low forecast of 33.71 USD and a high forecast of 90.3 USD.
Dividends
Current shareholder yield for ASTH is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Apollo Medical Holdings, Inc. is a physician-centric, technology-powered, risk-bearing healthcare management company. The company is headquartered in Alhambra, California and currently employs 1,133 full-time employees. The firm through its subsidiary provides care coordination services to each constituent of the healthcare delivery system, including patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups and health plans. Its physician network consists of primary care physicians, specialist physicians, and hospitalists. The company operates an integrated healthcare delivery platform that enables providers to participate in value-based care arrangements. To implement a patient-centered, physician-centric experience, the Company has other integrated and synergistic operations, including management service organizations (MSOs) that provide management and other services to its affiliated independent practice associations (IPAs), outpatient clinics, and hospitalists that coordinates the care of patients in hospitals.
Contact
IPO
Employees
Officers
The intrinsic value of one ASTH stock under the Base Case scenario is 57.11 USD.
Compared to the current market price of 42.11 USD, Apollo Medical Holdings Inc is Undervalued by 26%.